Sarvodaya Cancer Hospital Delhi NCR proudly announces the first-time availability of Radium-223 therapy in India for patients with castration-resistant prostate cancer (CRPC) and predominant skeletal metastases. This milestone marks a new era in precision oncology, offering hope to patients with advanced…
